RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5279
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0823100; Gene model (P.falciparum): PF3D7_0922200; Gene product: S-adenosylmethionine synthetase (SAMS)
Details mutation: The sams gene fused to the destabilizing domain (DD).
Details conditional mutagenesis: See below
Phenotype Asexual bloodstage;
Last modified: 23 February 2023, 11:13
  *RMgm-5279
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 36810637
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line that expresses GFP under the control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherMarreiros M, Mota MM
Name Group/DepartmentInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina
Name InstituteUniversidade de Lisboa
CityLisbon
CountryPortugal
Name of the mutant parasite
RMgm numberRMgm-5279
Principal namePbSAMS-DD
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageSee below: Additional information
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant contains a mutated sams gene where the sams gene has been fused to the destabilizing domain (DD) and a HA tag.

Protein stabilization in vivo was achieved by providing trimethoprim (TMP) in drinking water of mice for 2  days prior to infection (PbSAMS-DD +TMP), while SAMS  conditional knockdown (PbSAMS-DD -TMP) was achieved in non-TMP treated mice, as evidenced by a significant decrease in SAMS-HA-DD protein levels, measured by immunoblotting analysis.

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2022.12.01.518651

Protein (function)
SAMS is the first and rate-limiting enzyme of the methionine cycle. Methionine, among the twenty amino acids, plays an integral role in protein biosynthesis and in regulation of translation and global gene expression - as it is coded by the translation initiation codon. Met is metabolized into S-adenosylmethionine (SAM), the cellular methylation currency, via an ATP-dependent process which is catalyzed by the Plasmodium SAMS enzyme

Phenotype
See below

Additional information
Evidence is presented:
- that fluctuations in AA availability affect parasite growth, by either stalling progression through the intra-erythrocytic asexual cell cycle or by reducing parasite replication rates
- that P. berghei and P. falciparum parasites can actively mount a response to a decrease in two distinct amino acids (AAs) – methionine and isoleucine – by activating in each life cycle stage a different protein kinase, ultimately leading to a reprograming of replication and parasite development. 

Methionine, among the twenty amino acids, plays an integral role in protein biosynthesis and in regulation of translation and global gene expression - as it is coded by the translation initiation codon. Met is metabolized into S-adenosylmethionine (SAM), the cellular methylation currency, via an ATP-dependent process which is catalyzed by the Plasmodium SAMS enzyme.

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0823100
Gene Model P. falciparum ortholog PF3D7_0922200
Gene productS-adenosylmethionine synthetase
Gene product: Alternative nameSAMS
Details of the genetic modification
Short description of the mutationThe sams gene fused to the destabilizing domain (DD).
Inducable system usedDD
Short description of the conditional mutagenesisSee below
Additional remarks inducable system
Click to view information
Click to hide information
Protein stabilization in vivo was achieved by providing trimethoprim (TMP) in drinking water of mice for 2 days prior to infection (PbSAMS-DD +TMP), while SAMS conditional knockdown (PbSAMS-DD -TMP) was achieved in non-TMP treated mice, as evidenced by a significant decrease in SAMS-HA-DD protein levels, measured by immunoblotting analysis.
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe pPbsams.DD.HA construct contains a truncated Pbsams ORF in fusion with a destabilizing domain (DD) – a mutant form of the E. coli dihydrofolate reductase (ecDHFR) protein, engineered to be degraded - an HA tag and also a cassette for transgenic expression of the human dhfr - conferring resistance to pyrimethamine - which is flanked by the sams 3’UTR.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6